Hualan Biological (002007): Jingpi pulls blood products to grow steadily, waiting for tetravalent influenza vaccine to contribute elasticity

Hualan Biological (002007): Jingpi pulls blood products to grow steadily, waiting for tetravalent influenza vaccine to contribute elasticity Event: The company released its 2019 Interim Report, H1 achieved operating income14. 03 trillion, +16 a year. 77%; net profit attributable to mother 5. 070000 yuan, ten years +11. 94%; deducted non-attributed Continue Reading

Huafeng Spandex (002064) Major Asset Restructuring Review: The Group’s High-Quality Asset Securitization Creates a Leading Enterprise in the Global Polyurethane Products Industry

Huafeng Spandex (002064) Major Asset Restructuring Review: The Group’s High-Quality Asset Securitization Creates a Leading Enterprise in the Global Polyurethane Products Industry Key investment events: Huafeng Spandex issued shares and paid cash to purchase assets and raise supporting funds and related transaction plans. It intends to acquire Zhejiang Huafeng New Continue Reading

Bairun shares (002568) 2019H1 financial report comments: Interim report performance is higher than the indicator Wei Wei is expected to continue to add new momentum

Bairun shares (002568) 2019H1 financial report comments: Interim report performance is higher than the indicator Wei Wei is expected to continue to add new momentum Event: The company released its 2019 Interim Report and achieved operating income6.3.6 billion, an increase of 14 in ten years.39%; net profit attributable to mothers1.370,000 Continue Reading